Journal for Antimicrobial Chemotherapy-Medical Mycology Joint Issue

Aspergillosis continues to be a frequent cause of opportunistic infection and mortality among patients with suppressed immunity and those with airway diseases. This virtual issue is a joint endeavour between the Journal of Antimicrobial Chemotherapy and Medical Mycology to highlight the diagnosis and the clinical aspects of the management of chronic aspergillosis as well as the relatively new phenomenon of emergent azole resistance.

ISHAM hope the reader will find the collection useful in gaining new insights into aspergillosis from a laboratory and clinical perspective.